Table 3.
Ratio a | |
---|---|
4E-BP1(Thr36) | 1.15 |
4E-BP1(Thr45) | 6.65 |
Akt(Ser473) | 1.37 |
FOXO4(Ser197) | 1.52 |
Gab1(Tyr627) | 1.59 |
HSP27(Ser82) | 1.49 |
IKK α(Thr23) | 1.29 |
IRS-1(Ser307) | 2.73 |
IRS-1(Ser639) | 1.11 |
JNK(Thr183) | 1.56 |
PTEN(Ser380/Thr382/Thr383) | 1.97 |
Raf1(Ser259) | 1.18 |
For each treatment group, the phosphorylation signal ratio induction was calculated and further normalized by the ratio obtained from the untreated, control group, which was given a value of 1. The coefficients of variation for the fluorescence intensity are ≤ 6% from replicate spots and arrays; the CVs of phosphorylation signal ratio induction are therefore ≤ 12 %. The statistical analysis shows that the ratio change between PMA treatment and the control is significant with p < 0.05.